Metabolically healthy but obese, a matter of time? Findings from the prospective pizarra study

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 6, 2013, Pages 2318-2325

  Soriguer, Federico ^a,b,c   Gutiérrez Repiso, Carolina ^a,b,c   Rubio Martín, Elehazara ^a,b,c   García Fuentes, Eduardo ^a,b,c   Almaraz, María Cruz ^a,b,c   Colomo, Natalia ^a,b,d   De Antonio, Isabel Esteva ^a,b,c   De Adana, María Soledad Ruiz ^a,b,c   Chaves, Felipe Javier ^a,e   Morcillo, Sonsoles ^a,f   Valdés, Sergio ^a,b,c   Rojo Martínez, Gemma ^a,b,c  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^c Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina IBIMA Plataforma Bionand   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^f HOSPITAL DE CRUCES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPAIN;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBESITY; PHENOTYPE; PROSPECTIVE STUDIES; RISK;

EID: 84878490169     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-4253     Document Type: Article

References (36)

1. Soriguer F, Goday A, Bosch-Comas A, et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia. 2012;55:88-93.
2. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes. 1998;47:699-713. (Pubitemid 28201798)
3. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest. 1997;100:1166-1173.
4. Brochu M, Tchernof A, Dionne IJ, et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab. 2001;86:1020-1025. (Pubitemid 32322976)
5. Primeau V, Coderre L, Karelis AD, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond). 2011;35:971-981.
6. Kuk JL, Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care. 2009;32:2297-2299.
7. Aguilar-Salinas CA, García EG, Robles L, et al. High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab. 2008;93:4075-4079.
8. Lynch LA, O'Connell JM, Kwasnik AK, Cawood TJ, O'Farrelly C, O'Shea DB. Are natural killer cells protecting the metabolically healthy obese patient? Obesity (Silver Spring). 2009;17:601-605.
9. Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008;168:1617-1624.
10. Karelis AD, Rabasa-Lhoret R. Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals. Diabetes Metab. 2008;34:183-184.
11. Genelhu VA, Celoria BM, Duarte SF, Cabello PH, Francischetti EA. Not all obese subjects of multiethnic origin are at similar risk for developing hypertension and type 2-diabetes. Eur J Intern Med. 2009;20:289-295.
12. Jennings CL, Lambert EV, Collins M, Joffe Y, Levitt NS, Goedecke JH. Determinants of insulin-resistant phenotypes in normalweight and obese Black African women. Obesity (Silver Spring). 2008;16:1602-1609. (Pubitemid 351915104)
13. Karelis AD, Faraj M, Bastard JP, et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab. 2005;90:4145-4150. (Pubitemid 41058189)
14. Marini MA, Succurro E, Frontoni S, et al. Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. Diabetes Care. 2007;30:2145-2147. (Pubitemid 47219439)
15. Weiss R, Taksali SE, Dufour S, et al. The "obese insulin-sensitive" adolescent: importance of adiponectin and lipid partitioning. J Clin Endocrinol Metab. 2005;90:3731-3737. (Pubitemid 41014349)
16. Stefan N, Kantartzis K, Machann J, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008;168:1609-1616.
17. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. Prevalence of uncomplicated obesity in an Italian obese population. Obes Res. 2005;13:1116-1122.
18. McLaughlin T, Sherman A, Tsao P, et al. Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia. 2007;50:1707-1715. (Pubitemid 47036653)
19. Calori G, Lattuada G, Piemonti L, et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care. 2011;34:210-215.
20. Pajunen P, Kotronen A, Korpi-Hyövälti E, et al. Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey. BMC Public Health. 2011;11:754-761.
21. Lee K. Metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) phenotypes in Koreans: characteristics and health behaviors. Asia Pac J Clin Nutr. 2009;18:280-284.
22. Meigs JB, Wilson PW, Fox CS, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006;91:2906-2912. (Pubitemid 44271734)
23. Shin MJ, Hyun YJ, Kim OY, Kim JY, Jang Y, Lee JH. Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int J Obes (London). 2006;30:1529-1534. (Pubitemid 44470202)
24. St-Pierre AC, Cantin B, Mauriège P, et al. Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CMAJ. 2005;172:1301-1305. (Pubitemid 40745071)
25. Arnlöv J, Ingelsson E, Sundström J, Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation. 2010;121:230-236.
26. Chang Y, Ryu S, Suh BS, Yun KE, Kim CW, Cho SI. Impact of BMI on the incidence of metabolic abnormalities in metabolically healthy men. Int J Obes (Lond). 2011;36:1187-1194.
27. Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab. 2012;97:2482-2488.
28. Soriguer-Escofet F, Esteva I, Rojo-Martinez G, et al Diabetes Group of the Andalusian Society of Endocrinology and Nutrition. Prevalence of latent autoimmune diabetes of adults (LADA) in Southern Spain. Diabetes Res Clin Pract. 2002;56:213-220. (Pubitemid 34269662)
29. Soriguer F, Rojo-Martínez G, Almaraz MC, et al. Incidence of type 2 diabetes in southern Spain (Pizarra Study). Eur J Clin Invest. 2008;38:126-133. (Pubitemid 351147804)
30. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in ma. Diabelogia. 1985;28:412-419. (Pubitemid 15018832)
31. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-553. (Pubitemid 28319935)
32. Molarius A, Seidell JC. Selection of anthropometric indicators for classification of abdominal fatness - a critical review. Int J Obes. 1998;22:718-727.
33. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23:469-480.
34. Rojo-Martínez G, Esteva I, de Adana SR, et al. Patterns of insulin resistance in the general population of southeast Spain. Diabetes Res Clin Pract. 2004;65:247-256. (Pubitemid 39141181)
35. Ferrannini E, Natali A, Muscelli E, et al RISC Investigators. Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. Diabetologia. 2011;54:1507-1516.
36. Ogorodnikova AD, Kim M, McGinn AP, Muntner P, Khan U, Wildman RP. Incident cardiovascular disease events in metabolically benign obese individuals. Obesity (Silver Spring). 2012;20:651-659.